Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
Condition: Malignant Glioma Interventions: Radiation: Hypofractionated Stereotactic Radiotherapy; Drug: Anlotinib Sponsor: Huashan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials